Project 2:

A Pragmatic Trial of Chronic Disease Approaches To Ameliorate Tobacco Related Cardiovascular Disease

Hands lighting up a cigarette.

Select communities in the United States experience disproportionate health consequences from tobacco use, particularly commercial cigarettes. Among people who smoke, those communities experience a greater morbidity and mortality from tobacco related chronic diseases, especially CVD & RCC. Although there is numerous evidence based cessation treatments (EBCT) for tobacco cessation, during quit attempts, treatment utilization is low. This project aims to increase tobacco abstinence and reduce cardiovascular disease by better connecting primary care patients to evidence-based tobacco cessation treatment.

A doctor holding a phone and wearing a stethoscope.

Project 2 aims to:

  1. Conduct a hybrid type 1 implementation-effectiveness RCT to examine the direct effect of AAC+LPO vs. AAC on population-level smoking abstinence at 18 months and treatment utilization among 2,000 patients.

  2. Use a mixed methods approach to evaluate implementation outcomes of appropriateness, acceptability, and feasibility of AAC and LPO for patients.